-
Mashup Score: 0APCCC 2022: Tumor Genomic Profiling: What Is Relevant and How To Avoid Potential Pitfalls? - 2 year(s) ago
the 2022 Advanced Prostate Cancer Consensus Conference the treatment of patients with metastatic castration-resistant prostate cancer, the role of tumor genomic profiling in prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 17APCCC 2021: Novel and Not So Novel Agents and Where To Place Them in the Treatment Sequence for Prostate Cancer - 3 year(s) ago
APCCC 2021 the role of both novel and proven treatment options in advanced prostate cancer and how we may best utilize these in treatment sequencing.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Novel and not so novel agents and where to place them in the treatment sequence for #ProstateCancer. Presentation by Eric Small, MD @UCSFUrology. #APCCC21 coverage by @WallisCJD on UroToday > https://t.co/bpOay4qsFL @APCCC_Lugano @UCSFCancer @Silke_Gillessen @CaPsurvivorship https://t.co/q4Z5jUW4qH
-
-
Mashup Score: 8APCCC 2021: What Can Meta-Analyses, Network Meta-Analyses and Subgroup Analyses Tell Us About Treatment Options: Pearls and Pitfalls - 3 year(s) ago
APCCC 2021 the management of patients with newly diagnosed metastatic hormone-sensitive prostate cancer, analytic issues including the role of meta-analysis network meta-analysis and subgroup analyses to inform care for patients in metastatic hormone-sensitive prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What can meta-analyses, network meta-analyses, and subgroup analyses tell us about treatment options: pearls and pitfalls. Presented by Claire Vale, PhD @ucl. #APCCC21 written coverage by @WallisCJD on UroToday > https://t.co/hNmkpcdUJ4 @MRCCTU @APCCC_Lugano @Silke_Gillessen https://t.co/qyTdf90I4T
-
-
Mashup Score: 12APCCC 2021: Best Use of Lutetium-PSMA and Where To Put It in Sequencing Therapies Including Treatment Monitoring - 3 year(s) ago
APCCC 2021 PSMA in diagnostics and therapy, Lutetium-PSMA and where to place it when sequencing therapies, Lutetium-PSMA treatment monitoring prostate cancer.
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Best use of Lu-PSMA and where to put it in sequencing therapies including treatment monitoring. Presentation by @charlesryanmd @UMNCancer. #APCCC21 coverage by @zklaassen_md on UroToday > https://t.co/H8e8WhVjrY @PCFnews @APCCC_Lugano @Silke_Gillessen @CaPsurvivorship @WallisCJD https://t.co/XZtpCWmDXc
-
-
Mashup Score: 6APCCC 2021: Tumor Molecular Testing – Tissue vs Liquid Biopsy - 3 year(s) ago
APCCC 2021considerations regarding tumor molecular testing with a focus on implications for tissue-based testing as compared to liquid biopsy in prostate cancer
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
Tumor Molecular Testing – Tissue vs Liquid Biopsy. Presentation by @AarmstrongDuke @DukeCancer. #APCCC21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/TpgO2qoMhV @APCCC_Lugano @Silke_Gillessen @CaPsurvivorship https://t.co/oI274Me0sn
-
-
Mashup Score: 0APCCC 2021: DNA Repair Defect Aberrations – What Are the Differences Between Them and What Is the Impact on Patient Management? - 3 year(s) ago
APCCC 2021 PARP inhibitors, differences between DNA repair defect aberrations and the impact on patient management
Source: www.urotoday.comCategories: Latest Headlines, UrologyTweet-
DNA repair defect aberrations – What are the differences between them and what is the impact on patient management? Presented by @jodebon @royalmarsdenNHS. #APCCC21 coverage by @zklaassen_md on UroToday > https://t.co/WahA7XrRoq @ICR_London @APCCC_Lugano @Silke_Gillessen https://t.co/av7vLnP8Xd
-
-
Mashup Score: 8APCCC 2021: Who Needs Germline Testing – Prostate Cancer - 3 year(s) ago
NCCN guidelines for prostate cancer and gremlin testing, Germline Testing for prostate cancer
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Who needs germline testing - #ProstateCancer. Presentation by @DRathkopf @sloan_kettering. #APCCC21 written coverage by @zklaassen_md @GACancerCenter on UroToday > https://t.co/PfxenzLbWR @APCCC_Lugano @Silke_Gillessen @CaPsurvivorship https://t.co/8q8bJxRIjH
-
-
Mashup Score: 4APCCC 2021: Management of Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer: Review of Panel Responses and Discussion - 3 year(s) ago
APCCC 2021 the management of metastatic hormone sensitive prostate cancer (mHSPC)
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Management of newly diagnosed #mHSPC: Review of panel responses and discussion. Presented by @Prof_Nick_James @ICR_London and @BertrandTOMBAL @UCLouvain_be. #APCCC21 written coverage by @jberchuck @DanaFarber > https://t.co/eITCmqUBYk @APCCC_Lugano https://t.co/cyUbNn8GpH
-
-
Mashup Score: 4#APCCC21 - Advanced Prostate Cancer Society - Social Media Analytics and Transcripts - 3 year(s) ago
The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical
Source: SymplurCategories: Latest Headlines, Oncologists1Tweet-
RT @amerseburger: Top Influencers of #APCCC21 👉 @APCCC_Lugano @piet_ost @Prof_Nick_James @mishabeltran @urotoday https://t.co/kPPVe5QHZs vi…
-
-
Mashup Score: 2#APCCC21 - Advanced Prostate Cancer Society - Social Media Analytics and Transcripts - 3 year(s) ago
The Advanced Prostate Cancer Consensus Conference (APCCC) was initiated to provide a forum to discuss and debate current questions on the clinical
Source: SymplurCategories: Latest Headlines, Oncologists2Tweet-
RT @amerseburger: Top Influencers of #APCCC21 👉 @APCCC_Lugano @piet_ost @Prof_Nick_James @mishabeltran @urotoday https://t.co/kPPVe5QHZs vi…
-
Tumor genomic profiling: What is relevant and how to avoid potential pitfalls? Presentation by @ColinCPritchard @UW. #APCCC21 written coverage by @WallisCJD @UofT on UroToday > https://t.co/sF5GXTqOyZ @APCCC_Lugano https://t.co/OhXCJJVTCN